ATX-304 Capsules

ATX-304 Capsules is a small-molecule compound that primarily acts on intracellular "energy sensors," activating these sensors to encourage cells to consume more fat and glucose to generate energy.

In research applications, its focus is mainly on metabolic regulation, including promoting fat burning, improving blood glucose and lipid levels, and exploring its protective mechanisms in the liver and kidneys. Animal experiments have shown that it can assist in weight loss, with the weight loss primarily occurring from fat rather than muscle, and it exhibits synergistic effects when used in combination with GLP-1 compounds.

1. Promotes Fat Burning

In animal experiments, studies using ATX-304 have observed that adipose tissue is utilized more as an energy source rather than stored. This signifies a shift in cellular energy metabolism-from a "storage mode" to a "consumption mode." This characteristic makes ATX-304 a noteworthy research tool in weight management and fat metabolism-related topics. Notably, the weight loss in these experiments primarily came from fat, rather than muscle or water, which is a desirable observation for metabolic research.

2. Improves Metabolic Indicators

Some experimental data show that ATX-304 has a regulatory effect on blood glucose and lipid levels. In glucose and lipid metabolism models, it helps maintain a more stable energy balance. The significance of this research lies in the fact that glucose and lipid metabolism disorders are a common feature of many metabolic problems, and ATX-304 precisely acts on the upstream pathways regulating these two processes, thus providing valuable insights into the mechanisms of metabolic imbalance.

3. Explores Protective Effects

Besides metabolic regulation, ATX-304 has also been used to study some tissue protection mechanisms. For example, in the liver, some studies have used it in research on metabolic-related fatty liver disease to observe its effect on hepatic fat accumulation; in the kidneys, it has been used to explore the protective mechanism against damage caused by chemicals (such as certain drug components). The focus of these studies is not on "treatment," but rather on observing the protective effects of ATX-304 under specific injury conditions and the underlying molecular pathways through its metabolic regulatory functions.

Quality control of ATX-304 capsules is implemented throughout the entire process from raw material intake to finished product release, covering four core aspects: raw material testing, process control, finished product release, and laboratory capability assurance.

Raw Material Testing: Each batch undergoes HPLC and MS verification to confirm identity, purity (≥98%), and molecular weight, excluding structural analogs or isomers before production.

Process Control: Online monitoring covers fill weight uniformity, disintegration time in simulated fluids, and intermediate sampling after mixing/filling to detect any degradation or content migration.

Finished Product Testing

Three core tests must be completed before finished product release, as follows:

The quality control laboratory is equipped with core equipment such as HPLC (for purity and content determination) and GC-MS (for residual solvent detection), and also has microbial detection capabilities. In addition to internal full inspection, each batch of products can be sent to a CNAS-accredited third-party laboratory for parallel testing of purity, heavy metals, residual solvents, and microbial limits.

The production of ATX-304 capsules adopts industrial-grade manufacturing standards, with the entire process from raw material extraction to finished product packaging under strict control. The specific process steps are as follows:

• Extraction & Filtration: Based on raw material characteristics, water, acid, or CO₂ supercritical extraction is used under controlled temperature to dissolve target components. The crude extract is then filtered to remove plant residues and obtain a clear solution.

• Concentration & Drying: The clear extract is concentrated by vacuum evaporation to increase solid content, then spray-dried or freeze-dried depending on heat sensitivity to produce free-flowing powder suitable for encapsulation.

• Mixing, Standardization & Filling: The dried powder is blended with excipients in a three-dimensional mixer for content uniformity; active ingredient levels are adjusted to meet batch specifications. The blend is then filled into capsules, polished, and sealed in blister packs or bottles under controlled conditions.

• Process Control & Automation: Key parameters (temperature, time, vacuum, etc.) are preset with alarms for out-of-limit deviations. A PLC system monitors and adjusts parameters in real time; all operations follow SOPs with step-by-step review to ensure batch consistency and full traceability.